Rosuvastatin Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 142 Category: Pharma & Healthcare Report Code : HC117184
Rosuvastatin Market by Type (Purity 98.0%, Purity 99.0%, Other) Application (Capsule, Tablet, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The rosuvastatin market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Rosuvastatin is a prescription drug. Rosuvastatin is utilized to reduce LDL cholesterol levels and increase HDL cholesterol levels. It also reduces degrees of triglycerides (fats in your blood). Improving your cholesterol levels keeps blockages from forming in arteries. These blockages can cause difficult issues, including heart attack or stroke.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global rosuvastatin market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- AstraZeneca
- HEC Pharm
- Bal Pharma
- Teva Pharmaceutical Industries
- Zhejiang Hisun Pharmaceutical
- MSN Laboratories
- Jingxin Pharm
- Cadila Pharmaceuticals
- Changzhou Pharmaceutical Factory
- LGM Pharma
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Rosuvastatin Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Purity 98.0%
o Purity 99.0%
o Other
· Rosuvastatin Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Capsule
o Tablet
o Others
· Rosuvastatin Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o AstraZeneca
o HEC Pharm
o Bal Pharma
o Teva Pharmaceutical Industries
o Zhejiang Hisun Pharmaceutical
o MSN Laboratories
o Jingxin Pharm
o Cadila Pharmaceuticals
o Changzhou Pharmaceutical Factory
o LGM Pharma
· Rosuvastatin Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Rosuvastatin Market, By Country
o U.S. Rosuvastatin Market
o Canada Rosuvastatin Market
o Mexico Rosuvastatin Market
o Europe
§ Europe Rosuvastatin Market, By Country
o Germany Rosuvastatin Market
o UK Rosuvastatin Market
o France Rosuvastatin Market
o Russia Rosuvastatin Market
o Italy Rosuvastatin Market
o Rest of Europe Rosuvastatin Market
o Asia-Pacific
§ Asia-Pacific Rosuvastatin Market, By Country
o China Rosuvastatin Market
o Japan Rosuvastatin Market
o South Korea Rosuvastatin Market
o India Rosuvastatin Market
o Southeast Asia Rosuvastatin Market
o Rest of Asia-Pacific Rosuvastatin Market
o South America
§ South America Rosuvastatin Market
o Brazil Rosuvastatin Market
o Argentina Rosuvastatin Market
o Columbia Rosuvastatin Market
o Rest of South America Rosuvastatin Market
o Middle East and Africa
§ Middle East and Africa Rosuvastatin Market
o Saudi Arabia Rosuvastatin Market
o UAE Rosuvastatin Market
o Egypt Rosuvastatin Market
o Nigeria Rosuvastatin Market
o South Africa Rosuvastatin Market
o Rest of MEA Rosuvastatin Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Rosuvastatin Market, By Type
5.1. Introduction
5.2. Global Rosuvastatin Revenue and Market Share by Type (2017-2027)
5.2.1. Global Rosuvastatin Revenue and Revenue Share by Type (2017-2027)
5.3. Purity 98.0%
5.3.1. Global Purity 98.0% Revenue and Growth Rate (2017-2027)
5.4. Purity 99.0%
5.4.1. Global Purity 99.0% Revenue and Growth Rate (2017-2027)
5.5. Other
5.5.1. Global Other Revenue and Growth Rate (2017-2027)
6. Rosuvastatin Market, By Application
6.1. Introduction
6.2. Global Rosuvastatin Revenue and Market Share by Application (2017-2027)
6.2.1. Global Rosuvastatin Revenue and Revenue Share by Application (2017-2027)
6.3. Capsule
6.3.1. Global Capsule Revenue and Growth Rate (2017-2027)
6.4. Tablet
6.4.1. Global Tablet Revenue and Growth Rate (2017-2027)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2027)
7. Rosuvastatin Market, By Region
7.1. Introduction
7.2. Global Rosuvastatin Revenue and Market Share by Regions
7.2.1. Global Rosuvastatin Revenue by Regions (2017-2027)
7.3. North America Rosuvastatin by Countries
7.3.1. North America Rosuvastatin Revenue and Growth Rate (2017-2027)
7.3.2. North America Rosuvastatin Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Rosuvastatin by Countries
7.4.1. Europe Rosuvastatin Revenue and Growth Rate (2017-2027)
7.4.2. Europe Rosuvastatin Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Rosuvastatin by Countries
7.5.1. Asia-Pacific Rosuvastatin Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Rosuvastatin Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Rosuvastatin by Countries
7.6.1. South America Rosuvastatin Revenue and Growth Rate (2017-2027)
7.6.2. South America Rosuvastatin Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Rosuvastatin by Countries
7.7.1. Middle East and Africa Rosuvastatin Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Rosuvastatin Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. AstraZeneca
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. HEC Pharm
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Bal Pharma
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Teva Pharmaceutical Industries
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Zhejiang Hisun Pharmaceutical
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. MSN Laboratories
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Jingxin Pharm
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Cadila Pharmaceuticals
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Changzhou Pharmaceutical Factory
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. LGM Pharma
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Rosuvastatin Market Forecast (2017-2027)
9.1. Global Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Rosuvastatin Market Forecast by Regions (2017-2027)
9.2.1. North America Rosuvastatin Market Forecast (2017-2027)
9.2.1.1. United States Rosuvastatin Market Forecast (2017-2027)
9.2.1.2. Canada Rosuvastatin Market Forecast (2017-2027)
9.2.1.3. Mexico Rosuvastatin Market Forecast (2017-2027)
9.2.2. Europe Rosuvastatin Market Forecast (2017-2027)
9.2.2.1. Germany Rosuvastatin Market Forecast (2017-2027)
9.2.2.2. France Rosuvastatin Market Forecast (2017-2027)
9.2.2.3. UK Rosuvastatin Market Forecast (2017-2027)
9.2.2.4. Russia Rosuvastatin Market Forecast (2017-2027)
9.2.2.5. Italy Rosuvastatin Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Rosuvastatin Market Forecast (2017-2027)
9.2.3. Asia-Pacific Rosuvastatin Market Forecast (2017-2027)
9.2.3.1. China Rosuvastatin Market Forecast (2017-2027)
9.2.3.2. Japan Rosuvastatin Market Forecast (2017-2027)
9.2.3.3. Korea Rosuvastatin Market Forecast (2017-2027)
9.2.3.4. India Rosuvastatin Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Rosuvastatin Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Rosuvastatin Market Forecast (2017-2027)
9.2.4. South America Rosuvastatin Market Forecast (2017-2027)
9.2.4.1. Brazil Rosuvastatin Market Forecast (2017-2027)
9.2.4.2. Argentina Rosuvastatin Market Forecast (2017-2027)
9.2.4.3. Columbia Rosuvastatin Market Forecast (2017-2027)
9.2.4.4. Rest of South America Rosuvastatin Market Forecast (2017-2027)
9.2.5. Middle East and Africa Rosuvastatin Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Rosuvastatin Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Rosuvastatin Market Forecast (2017-2027)
9.2.5.3. Egypt Rosuvastatin Market Forecast (2017-2027)
9.2.5.4. Nigeria Rosuvastatin Market Forecast (2017-2027)
9.2.5.5. South Africa Rosuvastatin Market Forecast (2017-2027)
9.2.5.6. Turkey Rosuvastatin Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Rosuvastatin Market Forecast (2017-2027)
9.3. Rosuvastatin Market Forecast by Type (2017-2027)
9.3.1. Rosuvastatin Forecast by Type (2017-2027)
9.3.2. Rosuvastatin Market Share Forecast by Type (2017-2027)
9.4. Rosuvastatin Market Forecast by Application (2017-2027)
9.4.1. Rosuvastatin Forecast by Application (2017-2027)
9.4.2. Rosuvastatin Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Rosuvastatin Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Rosuvastatin Revenue and Revenue Share by Type (2017-2018)
Figure Global Purity 98.0% Revenue and Growth Rate (2017-2018)
Figure Global Purity 99.0% Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Rosuvastatin Revenue and Revenue Share by Application (2017-2018)
Figure Global Capsule Revenue and Growth Rate (2017-2018)
Figure Global Tablet Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Rosuvastatin Revenue by Regions (2017-2018)
Figure North America Rosuvastatin Growth Rate (2017-2018)
Figure North America Rosuvastatin Revenue and Growth Rate (2017-2018)
Figure North America Rosuvastatin by Countries (2017-2018)
Figure North America Rosuvastatin Revenue (Million USD) by Countries (2017-2018)
Figure United States Rosuvastatin Growth Rate (2017-2018)
Figure United States Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Rosuvastatin Growth Rate (2017-2018)
Figure Canada Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Rosuvastatin Growth Rate (2017-2018)
Figure Mexico Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Rosuvastatin Growth Rate (2017-2018)
Figure Europe Rosuvastatin Revenue and Growth Rate (2017-2018)
Figure Europe Rosuvastatin by Countries (2017-2018)
Figure Europe Rosuvastatin Revenue (Million USD) by Countries (2017-2018)
Figure Germany Rosuvastatin Growth Rate (2017-2018)
Figure Germany Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Rosuvastatin Growth Rate (2017-2018)
Figure France Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Rosuvastatin Growth Rate (2017-2018)
Figure UK Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Rosuvastatin Growth Rate (2017-2018)
Figure Russia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Rosuvastatin Growth Rate (2017-2018)
Figure Italy Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Rosuvastatin Growth Rate (2017-2018)
Figure Rest of Europe Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Rosuvastatin Growth Rate (2017-2018)
Figure Asia-Pacific Rosuvastatin Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Rosuvastatin by Countries (2017-2018)
Figure Asia-Pacific Rosuvastatin Revenue (Million USD) by Countries (2017-2018)
Figure China Rosuvastatin Growth Rate (2017-2018)
Figure China Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Rosuvastatin Growth Rate (2017-2018)
Figure Japan Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Rosuvastatin Growth Rate (2017-2018)
Figure Korea Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Rosuvastatin Growth Rate (2017-2018)
Figure India Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Rosuvastatin Growth Rate (2017-2018)
Figure Southeast Asia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Rosuvastatin Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Rosuvastatin Growth Rate (2017-2018)
Figure South America Rosuvastatin Revenue and Growth Rate (2017-2018)
Figure South America Rosuvastatin by Countries (2017-2018)
Figure South America Rosuvastatin Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Rosuvastatin Growth Rate (2017-2018)
Figure Brazil Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Rosuvastatin Growth Rate (2017-2018)
Figure Argentina Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Rosuvastatin Growth Rate (2017-2018)
Figure Columbia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Rosuvastatin Growth Rate (2017-2018)
Figure Rest of South America Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Rosuvastatin Growth Rate (2017-2018)
Figure Middle East and Africa Rosuvastatin Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Rosuvastatin by Countries (2017-2018)
Figure Middle East and Africa Rosuvastatin Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Rosuvastatin Growth Rate (2017-2018)
Figure Saudi Arabia Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Rosuvastatin Growth Rate (2017-2018)
Figure United Arab Emirates Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Rosuvastatin Growth Rate (2017-2018)
Figure Egypt Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Rosuvastatin Growth Rate (2017-2018)
Figure Nigeria Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Rosuvastatin Growth Rate (2017-2018)
Figure South Africa Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Rosuvastatin Growth Rate (2017-2018)
Figure Turkey Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Rosuvastatin Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Rosuvastatin Revenue (Millions USD) and Growth Rate (2017-2018)
Table AstraZeneca Rosuvastatin Financial Overview
Table HEC Pharm Rosuvastatin Financial Overview
Table Bal Pharma Rosuvastatin Financial Overview
Table Teva Pharmaceutical Industries Rosuvastatin Financial Overview
Table Zhejiang Hisun Pharmaceutical Rosuvastatin Financial Overview
Table MSN Laboratories Rosuvastatin Financial Overview
Table Jingxin Pharm Rosuvastatin Financial Overview
Table Cadila Pharmaceuticals Rosuvastatin Financial Overview
Table Changzhou Pharmaceutical Factory Rosuvastatin Financial Overview
Table LGM Pharma Rosuvastatin Financial Overview
Figure Global Rosuvastatin Revenue (Millions USD) and Growth Rate (2018-2025)
Table Rosuvastatin Market Forecast by Regions (2018-2025)
Figure North America Rosuvastatin Market Forecast (2018-2025)
Figure United States Rosuvastatin Market Forecast (2018-2025)
Figure Canada Rosuvastatin Market Forecast (2018-2025)
Figure Mexico Rosuvastatin Market Forecast (2018-2025)
Figure Europe Rosuvastatin Market Forecast (2018-2025)
Figure Germany Rosuvastatin Market Forecast (2018-2025)
Figure France Rosuvastatin Market Forecast (2018-2025)
Figure UK Rosuvastatin Market Forecast (2018-2025)
Figure Russia Rosuvastatin Market Forecast (2018-2025)
Figure Italy Rosuvastatin Market Forecast (2018-2025)
Figure Rest of Europe Rosuvastatin Market Forecast (2018-2025)
Figure Asia-Pacific Rosuvastatin Market Forecast (2018-2025)
Figure China Rosuvastatin Market Forecast (2018-2025)
Figure Japan Rosuvastatin Market Forecast (2018-2025)
Figure Korea Rosuvastatin Market Forecast (2018-2025)
Figure India Rosuvastatin Market Forecast (2018-2025)
Figure Southeast Asia Rosuvastatin Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Rosuvastatin Market Forecast (2018-2025)
Figure South America Rosuvastatin Market Forecast (2018-2025)
Figure Brazil Rosuvastatin Market Forecast (2018-2025)
Figure Argentina Rosuvastatin Market Forecast (2018-2025)
Figure Columbia Rosuvastatin Market Forecast (2018-2025)
Figure Rest of South America Rosuvastatin Market Forecast (2018-2025)
Figure Middle East and Africa Rosuvastatin Market Forecast (2018-2025)
Figure Saudi Arabia Rosuvastatin Market Forecast (2018-2025)
Figure United Arab Emirates Rosuvastatin Market Forecast (2018-2025)
Figure Egypt Rosuvastatin Market Forecast (2018-2025)
Figure Nigeria Rosuvastatin Market Forecast (2018-2025)
Figure South Africa Rosuvastatin Market Forecast (2018-2025)
Figure Turkey Rosuvastatin Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Rosuvastatin Market Forecast (2018-2025)
Figure Global Rosuvastatin Forecast by Type (2018-2025)
Figure Global Rosuvastatin Market Share Forecast by Type (2018-2025)
Figure Global Rosuvastatin Forecast by Type (2018-2025)
Figure Global Rosuvastatin Forecast by Application (2018-2025)
Figure Global Rosuvastatin Market Share Forecast by Application (2018-2025)
Figure Global Rosuvastatin Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|